Ferric Carboxymaltose API Manufacturer & Supplier in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Ferric Carboxymaltose API Manufacturer and Supplier in India

Ferric Carboxymaltose is an intravenous iron replacement active pharmaceutical ingredient used for the treatment of iron deficiency and iron deficiency anemia in appropriate clinical settings. It is a stable iron-carbohydrate complex designed to deliver iron for replenishment of body iron stores.

Ferric Carboxymaltose is identified by CAS Number 9007-72-1. Unlike conventional small-molecule APIs, Ferric Carboxymaltose is a complex macromolecular iron-carbohydrate preparation, so its characterization and quality control differ from those of conventional low-molecular-weight drug substances.

About Ferric Carboxymaltose

Ferric Carboxymaltose consists of an iron-containing carbohydrate complex in which iron is associated with a carboxymaltose carbohydrate ligand. Following intravenous administration, iron is gradually made available for incorporation into physiological iron-utilization pathways.

It is used in pharmaceutical formulations intended for intravenous iron replacement, particularly when oral iron is ineffective, poorly tolerated or when rapid iron replenishment is clinically appropriate.

Mechanism of Action

Ferric Carboxymaltose provides iron for physiological utilization. The supplied iron is incorporated into hemoglobin and other iron-containing proteins after processing and utilization by the body's iron-handling pathways.

Replenishment of iron stores supports erythropoiesis and hemoglobin synthesis in patients with iron deficiency.

Pharmaceutical Applications

Ferric Carboxymaltose is used in pharmaceutical products for the treatment of iron deficiency and iron deficiency anemia in appropriate patient populations.

Depending on the applicable regulatory authorization, it may be used where:

  • Oral iron therapy is ineffective
  • Oral iron cannot be used or is not tolerated
  • Rapid iron replacement is clinically required
  • Iron deficiency is associated with chronic disease or other approved conditions

The exact indication, dosage and administration requirements should follow the approved product labeling in the relevant market.

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
pH (1% Solution) 5.5 – 6.5
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 1.0%
Melting Point 150°C – 154°C
Get Bulk Quote via WhatsApp